Is ARTL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.

ARTL (Artelo Biosciences, Inc. Common Stock) Stock Analysis - Financials

Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of July 13, 2026, ARTL trades at $1.03 with a market cap of $3.76M and a P/E ratio of 0.00. ARTL moved -3.70% today. Year to date, ARTL is -69.83%; over the trailing twelve months it is -98.53%. Its 52-week range spans $0.96 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ARTL's key financials?

ARTL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ARTL recently traded at $1.03. Market cap is $3.76M. P/E ratio is 0.00. Revenue is $0.

ARTL Key Metrics

Key financial metrics for ARTL
Metric	Value
Price	$1.03
Market Cap	$3.76M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$85.80
52-Week Low	$0.96
Volume	390.38K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-9.83M
Gross Margin	0.00%

ARTL Analyst Consensus

ARTL analyst coverage data. Average price target: $0.00.

Common questions about ARTL

What are ARTL's key financials?: ARTL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ARTL recently traded at $1.03. Market cap is $3.76M. P/E ratio is 0.00. Revenue is $0.
Is ARTL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.